Peptide Purity Explained
Quick answer: A reported peptide purity percentage is usually a method-specific estimate of the target peak relative to other detected peaks. It is not a complete safety score, sterility result, potency guarantee, or proof that the labeled amount is present.
Why 99% is not the whole story
Purity is often presented as a single number because it is easy to market. The number depends on the analytical method, detection wavelength, integration choices, sample preparation, reference standards, and what the method can detect. Different laboratories can produce different values from the same material.
Purity versus assay
Purity asks how clean the material appears relative to detected impurities. Assay asks how much active material is present. A vial can report high chromatographic purity but contain less total peptide than the label claims. Water and counter-ions can also affect mass calculations.
Sterility and endotoxin are separate
Neither HPLC purity nor mass-spectrometry identity establishes sterility. Injectable products bypass key body defenses, so microbial contamination and endotoxin are separate critical concerns.
Use a test panel, not a vanity number
A meaningful quality discussion asks which methods were used, whether the actual batch was tested, whether the laboratory was independent, and which risks remain untested. Read the companion COA guide before treating a percentage as proof.
How chromatographic area percentages work
A laboratory may integrate peaks and report the target peak as a percentage of total detected peak area. Response factors can differ among compounds, so area percentage is not always identical to mass percentage.
What can hide outside the purity result
- Water content
- Counter-ions and salts
- Residual solvents
- Metals or inorganic contaminants
- Microorganisms and endotoxin
- Incorrect fill amount
- Compounds not detected by the selected method
Why method details matter
Column, mobile phase, detector, wavelength, gradient, integration settings, and reference standards influence the result. Two laboratories can report different values without either necessarily committing misconduct.
Ask for assay and identity together
A stronger quality picture combines identity, purity, assay, fill amount, and product-specific safety tests. One number should not carry the entire marketing claim.
Purity is not clinical evidence
Even a correctly identified, highly pure compound can be ineffective, unsafe, or unapproved. Analytical quality and clinical benefit are separate dimensions.
Degradants can retain biological activity
An impurity is not necessarily inert. Related peptides or aggregates can have different activity or immune effects. Knowing the percentage does not reveal the toxicology of each impurity.
Batch consistency matters
A single excellent batch cannot establish ongoing quality. Trends across lots, manufacturing controls, deviations, complaints, and recalls provide a broader picture.
How to read marketing language
\u201cUp to 99%,\u201d \u201caverage 99%,\u201d and \u201cgreater than 98%\u201d are different claims. Ask whether the number refers to every lot, a selected sample, or a supplier specification.